Donating to the Cancer Impact Booster
Are you interested in boosting our investment in cutting-edge cancer start-ups?
£7.4m
Seed Fund committed to date
£32.7m
co-investment secured to date
19
new investments to date
7
pending investments
Translating science into impact
Through advances in technology, we’re on the threshold of a golden age of scientific progress against cancer. Start-ups are one of the fastest ways of translating that progress into impact for patients.
But there’s a funding gap between cutting-edge academic cancer research and a start-up becoming ready for commercial investment. Too many potential treatments, devices and innovations are lost here.
We have an opportunity to deliver huge future impact for patients by supporting start-ups through this gap. Which is why we committed £15m to a Seed Fund which accelerates high-potential, early-stage innovations into patient impact through seed funding, expert networks and business building support. Any financial returns generated are reinvested in the fund and into more cancer research.
The Horizons Seed Fund represents an exciting opportunity for us to support the very best early-stage discovery research through to potentially life-changing benefits for patients, and we’re delighted to be supporting Cancer Research UK with this new venture